Moderna, which created its shots with the US National Institutes of Health, said it got the final needed results over the weekend that suggest the vaccine is more than 94 percent effective
Coronavirus Updates: 144 Maharashtra Police personnel test COVID-19 positive over past 24 hrs, cases rise to 24,023 in force
Coronavirus LIVE Updates: The Maharashtra Police said that 144 police personnel tested positive for COVID-19 in the last 24 hours, taking total cases to 24,023 in the force including 21,030 recoveries, 2,743 active cases and 250 deaths
COVID-19 recovery rate crosses 83%, but new sero-survey shows 90% Indians at risk; M Venkaiah Naidu tests positive
Vice President of India M Venkaiah Naidu has tested positive for coronavirus and is under home quarantine, Tamil Nadu has extended the ongoing lockdown till 31 October, India's recovery rate has crossed 83%; the latest covid-19 updates from India
India surpasses US in global COVID-19 recoveries as tally exceeds 53 lakh; SII to begin phase III trials from Monday
Apart from the Oxford candidate, two more vaccine candidates in India are in advanced stages of clinical trials, while four are in pre-clinical development stage
The vaccine procurement and distribution effort, involving over 170 economies, has the potential to become the largest and fastest of its kind
COVID-19 vaccine to cost Rs 225 per dose in India says Serum Institute, will be made available to 92 nations
Serum Institute partners with Gavi and Bill & Melinda Gates Foundation to manufacture, deliver of up to 100 million doses of COVID-19 vaccines to India, other low and middle-income countries.
Coronavirus Updates: As many as 2,326 patients recovered during the day, the state health department said, taking the total number of recoveries to over 2.99 lakh
COVID-19 Vaccine Update: Novavax starts phase I/II clinical trials, here's all you need to know about the vaccine
Named NVX‑CoV2373, Novavax’s vaccine is created using recombinant protein nanoparticle technology.
COVID-19 vaccine update: Chinese vaccine Phase 1 trial results show some promise but also a few temporary side-effects
As per the study, about 81% of all the participants showed at least one adverse reaction to the vaccine within the first seven days.
COVID-19 Vaccine Update: Harvard studies show DNA vaccines provide partial immunity and antibodies prevent reinfection
One thing that the world didn’t know so far was if an infected person who recovers from the infection is safe from reinfection.
Medical team in Bangladesh suggests combination of Ivermectin and Doxycycline for COVID-19 treatment
As per media reports, the team tested a combination of the antiparasitic drug Ivermectin and the antibiotic Doxycycline on a group of 60 COVID-19 patients.